GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » ROE % Adjusted to Book Value

TRUMY (Terumo) ROE % Adjusted to Book Value : 2.96% (As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Terumo ROE % Adjusted to Book Value?

Terumo's ROE % for the quarter that ended in Sep. 2024 was 8.93%. Terumo's PB Ratio for the quarter that ended in Sep. 2024 was 3.02. Terumo's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 2.96%.


Terumo ROE % Adjusted to Book Value Historical Data

The historical data trend for Terumo's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo ROE % Adjusted to Book Value Chart

Terumo Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.19 2.74 3.39 3.28 2.69

Terumo Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.79 3.40 2.65 - 2.96

Competitive Comparison of Terumo's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Terumo's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Terumo's ROE % Adjusted to Book Value falls into.



Terumo ROE % Adjusted to Book Value Calculation

Terumo's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.27% / 3.08
=2.69%

Terumo's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.93% / 3.02
=2.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Terumo ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Terumo's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Terumo Business Description

Traded in Other Exchanges
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo Headlines

From GuruFocus

Q1 2020 Terumo Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q3 2021 Terumo Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2023 Terumo Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2024 Terumo Corp Earnings Presentation Transcript

By GuruFocus Research 02-15-2024

Q3 2023 Terumo Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2024 Terumo Corp Earnings Presentation Transcript

By GuruFocus Research 02-15-2024

Q2 2022 Terumo Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2021 Terumo Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2020 Terumo Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024